360b-shutterstock-com-16
360b / Shutterstock.com
29 July 2016Americas

Vectura sues GSK for patent infringement

Pharmaceutical company Vectura has sued GSK for allegedly infringing its patent after claiming that it refused to expand on a licensing agreement.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
17 December 2018   The English High Court has ruled in favour of GSK in its patent dispute with Vectura, a UK-based pharmaceutical company which specialises in inhalable medicaments.
Americas
7 May 2019   British drugmaker Vectura has succeeded in its patent litigation against fellow UK pharmaceutical company GlaxoSmithKline over a series of drugs delivered through GSK’s ‘Ellipta’ dry powder inhaler.

More on this story

Big Pharma
17 December 2018   The English High Court has ruled in favour of GSK in its patent dispute with Vectura, a UK-based pharmaceutical company which specialises in inhalable medicaments.
Americas
7 May 2019   British drugmaker Vectura has succeeded in its patent litigation against fellow UK pharmaceutical company GlaxoSmithKline over a series of drugs delivered through GSK’s ‘Ellipta’ dry powder inhaler.

More on this story

Big Pharma
17 December 2018   The English High Court has ruled in favour of GSK in its patent dispute with Vectura, a UK-based pharmaceutical company which specialises in inhalable medicaments.
Americas
7 May 2019   British drugmaker Vectura has succeeded in its patent litigation against fellow UK pharmaceutical company GlaxoSmithKline over a series of drugs delivered through GSK’s ‘Ellipta’ dry powder inhaler.